HOME ABOUT GENOPTIX TEST MENU PATIENTS BILLING CAREERS GENOPTIX ONLINE SEARCH BLOOD AND BONE MARROW CANCERS (Leukemia, Lymphoma, Myeloma) A confident and actionable diagnosis OUR COMPREHENSIVE ASSESSMENT APPROACH Blood cancers affect the production and function of blood cells, and often start in the bone marrow. In most cases, the normal blood cell development process is interrupted by uncontrolled growth of an abnormal type of blood cell. These cancerous cells prevent the blood components from performing their vital functions, like fighting off infection or clotting. ADVANCES The medical community has made exciting strides in the diagnosis and treatment of blood disorders. Markers have been identified that help distinguish similar disorders that were previously difficult to separate. Targeted therapies are now available which match the cancer cells’ molecular profile, so that they (unlike traditional radiation and chemotherapy) fight the disease while minimizing harm to normal cells. HOW GENOPTIX HELPS COMPASS®, our comprehensive assessment approach for bone marrow and blood workups, provides definite answers for patients with blood cell abnormalities. Combining results from a range of relevant technologies, we provide a confident diagnosis and assist your doctor in choosing the best treatment options. SOLID ORGAN TUMORS (Lung Cancer, Colorectal Cancer, Melanoma, Breast Cancer) Determine your best course of treatment A BETTER WAY TO CHOOSE YOUR THERAPY Cancer can originate from any tissue in the body, though it is more common in certain organs such as the large intestine (colon), lung, and female breast. Cell growth is normally a strictly organized process, but cancer cells acquire changes that allow them to grow out of control, often forming a mass. These tumor cells may invade into adjacent areas, or even spread to distant parts of the body. ADVANCES In recent years, the medical community has made major breakthroughs in understanding the specific genetic mutations associated with the development of many different types of cancer. After decades of limited treatment options, there are now new ways to fight cancer: targeted therapies based on a tumor’s molecular profile. HOW GENOPTIX HELPS Using powerful molecular tests that target specific markers (including Next-Generation Sequencing), Genoptix can help your doctor predict which treatments you are likely to respond to and which may be ineffective or toxic. CONTACT US Genoptix, a NeoGenomics Company 2131 Faraday Ave Carlsbad, CA 92008 Phone: +1.760.268.6200 Fax: +1.760.268.6201 Client Services Phone: +1.800.755.1605 Fax: +1.888.755.1604 Email: clientservices@genoptix.com Medical Director: Derek Lyle, MD RECENT NEWS NeoGenomics Completes Acquisition of Genoptix, Inc. December 10, 2018 - 9:00 am NeoGenomics Signs Definitive Agreement to Acquire Genoptix October 23, 2018 - 9:00 am Genoptix Launches FDA-Authorized BCR-ABL MRDx® TFR Monitoring Test for Patients with Chronic Myeloid Leukemia on Tasigna® (nilotinib) September 4, 2018 - 8:30 am HOURS OF OPERATION Our lab is open six days a week: 5:00am to 6:00pm PT Mon-Fri 7:00am to 3:30pm PT Saturday For after-hours assistance, your call will be connected with an on-duty Client Services Representative. ©2018 Genoptix, Inc. All rights reserved. Legal Pay My Bill